Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma (reply)

Springer Science and Business Media LLC - Tập 2 Số 6 - Trang 322-324 - 2000
Santiago González Moreno1, Paul H. Sugarbaker1
1Washington Cancer Institute

Tóm tắt

Từ khóa


Tài liệu tham khảo

Brennan MF. Lymph-node dissection for gastric cancer. N Engl J Med 1999; 340 (12): 956–958.

Cushieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 1999; 79 (9/10): 1.522–1.530.

Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340 (12): 908–914.

Hartgrink HH, Bonenkamp HJ, Van de Velde CJ. Influence of surgery on outcomes in gastric cancer. Surg Oncol Clin N Am 2000; 9(1): 97–117.

Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345 (8.952): 745–748.

Cushieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347 (9.007): 995–999.

Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998; 228 (3): 347–354.

Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979; 39: 3.861–3.865.

Sugarbaker PH. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, ed. Peritoneal carcinomatosis: principles of management. Boston, Massachusetts: Kluwer Academic Publishers, 1996; 79–100.

Sautner T, Hofbauer F, Depisch D, Shiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994; 12: 970–974.

Yonemura Y, Ninomiya I, Kaji M, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal-invasion positive gastric cancer. World J Surg 1995; 19: 450–455.

Hirose K, Katayama K, Iida A, et al. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 1999; 57 (2): 106–114.

Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994; 18: 150–155.

Hamazoe R, Maeta M, Kaibara N. Intraperitoneal termochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 1994; 73: 2.048–2.052.

Koga S, Hamazoe R, Maeta M, Shimizu N, Marakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988; 61: 232–237.